Effects of ifenprodil, a polyamine site NMDA receptor antagonist, on reperfusion injury after transient focal cerebral ischemia

Journal of Neurosurgery

Volumn 87, Issue 6, 1997, Pages 921-926

  Doǧan, Aclan ^a   Rao, A Muralikrishna ^a   Başkaya, Mustafa K ^a   Rao, V L Raghavendra ^a   Rastl, Jane ^a   Donaldson, David ^a   Dempsey, Robert J ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

Blood brain barrier breakdown; Cerebral edema; Cerebral ischemia; Ifenprodil; Rat; Reperfusion

Indexed keywords

DRUG VEHICLE; EVANS BLUE; IFENPRODIL; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; POLYAMINE; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD BRAIN BARRIER; BRAIN EDEMA; BRAIN INFARCTION; BRAIN ISCHEMIA; BRAIN WATER; CAROTID ARTERY OBSTRUCTION; CONTRAST MEDIUM EXTRAVASATION; CONTROLLED STUDY; DRUG EFFECT; INTRAVENOUS DRUG ADMINISTRATION; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; RAT; REPERFUSION INJURY; SPONTANEOUSLY HYPERTENSIVE RAT;

EID: 1842405463     PISSN: 00223085     EISSN: None     Source Type: Journal    
DOI: 10.3171/jns.1997.87.6.0921     Document Type: Article

References (48)

1. Baker AJ, Zornow MH, Scheller MS, et al: Changes in extracellular concentrations of glutamate, aspartate, glycine, dopamine, serotonin, and dopamine metabolites after transient global ischemia in the rabbit brain. J Neurochem 57:1370-1379, 1991
2. Başkaya MK, Rao AM, Donaldson D, et al: Protective effects of ifenprodil on ischemic injury size, blood-brain barrier breakdown, and edema formation in focal cerebral ischemia. Neurosurgery 40:364-371, 1997
3. Beart PM, Sheehan KAM, Manallack DT: Absence of N-methyl-D-aspartate receptors on bovine cerebral microvessels. J Cereb Blood Flow Metab 8:879-882, 1988
4. Bederson JB, Pitts LH, Germano SH, et al: Evaluation of 2,3,5-triphenyltetrazolium chloride as a stain for detection and quantification of experimental cerebral infarction in rats. Stroke 17:1304-1308, 1986
5. Benveniste H, Drejer J, Schousboe A, et al: Elevation of the extracellular concentrations of glutamate and aspartate in rat hippocampus during transient cerebral ischemia monitored by intracerebral microdialysis. J Neurochem 43:1369-1374, 1984
6. Betz AL, Martz D, Randall J: Free radicals, ischemia, xanthine oxidase and the brain capillary, in Johansson BB, Owman C, Widner H (eds): Pathophysiology of the Blood-Brain Barrier. Long Term Consequences of Barrier Dysfunction for the Brain. Amsterdam: Elsevier, 1990, pp 333-341
7. Brint S, Jacewicz M, Kiessling M, et al: Focal brain ischemia in the rat: methods for reproducible neocortical infarction using tandem occlusion of the distal middle cerebral artery and ipsilateral common carotid artery. J Cereb Blood Flow Metab 8: 474-485, 1988
8. Butcher SP, Bullock R, Graham DI, et al: Correlation between amino acid release and neuropathologic outcome in rat brain following middle cerebral artery occlusion. Stroke 21: 1727-1733, 1990
9. Carron C, Jullien A, Bucher B: Synthesis and pharmacological properties of a series of 2-piperidino alkanol derivatives. Arzneimittelforschung 21:1988-1992, 1971
10. Carter C, Benavides J, Legendre P, et al: Ifenprodil and SL 82.0715 as cerebral anti-ischemic agents. II. Evidence for N-methyl-D-aspartate receptor antagonist properties. J Pharmacol Exp Ther 247:1222-1232, 1988
11. Cavazzuti M, Porro CA, Biral GP, et al: Ketamine effects on local cerebral blood flow and metabolism in the rat. J Cereb Blood Flow Metab 7:806-811, 1987
12. Chan PH, Chu L: Mechanisms underlying glutamate-induced swelling of astrocytes in primary culture. Acta Neurochir Suppl 51:7-10, 1990
13. Chan PH, Fishman RA, Lee JL, et al: Effects of excitatory neurotransmitter amino acids on swelling of rat brain cortical slices. J Neurochem 33:1309-1315, 1979
14. Chen J, Zarow G, Graham SH: Duration threshold of ischemia of early reperfusion injury in reversible focal ischemia model. Stroke 22:127, 1991 (Abstract)
15. Choi D: Excitotoxic cell death. J Neurobiol 23:1261-1276, 1992
16. Choi DW: Glutamate neurotoxicity in cortical cell culture is calcium dependent. Neurosci Lett 58:293-297, 1985
17. Contreras PC, Bremer ME, Gray NM: Ifenprodil and SL 82.0715 potently inhibit binding of [3H] (+)-3-PPP to σ binding sites in rat brain. Neurosci Lett 116:190-193, 1990
18. Cudennec A, Duverger D, Benavides B, et al: Effect of eliprodil, an NMDA receptor antagonist acting at the polyamine modulatory site, on local cerebral glucose use in the rat brain. Brain Res 664:41-48, 1994
19. Foster AC, Wong EHF: The novel anticonvulsant MK-801 binds to the activated state of the N-methyl-D-aspartate receptor in rat brain. Br J Pharmacol 91:403-409, 1987
20. Gotti B, Benavides J, MacKenzie ET, et al: The pharmacotherapy of focal cerebral ischaemia in the mouse. Brain Res 522: 290-307, 1990
21. Gotti B, Duverger D, Bertin J, et al: Ifenprodil and SL 82.0713 as cerebral anti-ischemic agents: I. Evidence for efficacy in models of focal cerebral ischemia. J Pharmacol Exp Ther 247:1211-1221, 1991
22. Graham SH, Shiraishi K, Panter SS, et al: Changes in extracellular amino acid neurotransmitters produced by focal cerebral ischemia. Neurosci Lett 110:124-130, 1990
23. Ito U, Ohno K, Nakamura R, et al: Brain edema during ischemia and after restoration of blood flow. Measurement of water, sodium, potassium content and plasma protein permeability. Stroke 10:542-547, 1979
24. Johnson JW, Ascher P: Glycine potentiates the NMDA response in cultured mouse brain neurons. Nature 325:529-331, 1987
25. 3H](+)-3-PPP labeled a binding sites in guinea pig brain membranes. Eur J Pharmacol 176:247-248, 1990
26. Klatzo I: Brain oedema following brain ischaemia and the influence of therapy. Br J Anaesthesiol 57:18-22, 1985
27. 2+ influx and transmitter release. J Neurochem 52 (Suppl):S42, 1989 (Abstract)
28. Kuroiwa T, Shibutani M, Okeda R: Blood-brain barrier disruption and exacerbation of ischemic brain edema after restoration of blood flow in experimental cerebral ischemia. Acta Neuropathol 76:62-70, 1988
29. Kurumaji A, Nehls DG, Park CK, et al: Effects of NMDA antagonists, MK-801 and CPP, upon local cerebral glucose use. Brain Res 496:268-284, 1989
30. Lehmann J, Schneider J, McPherson S, et al: CPP, a selective N-methyl-D-aspartate (NMDA)-type receptor antagonists: characterization in vitro and in vivo. J Pharmacol Exp Ther 240:737-746, 1987
31. Macrae IM: New models of focal cerebral ischaemia. Br J Clin Pharmacol 34:302-308, 1992
32. McCulloch J: Excitatory amino acid antagonists and their potential for the treatment of ischemic brain damage in man. Br J Clin Pharmacol 34:106-114, 1992
33. Morikawa E, Ginsberg MD, Dietrich WD, et al: The significance of brain temperature in focal cerebral ischemia: histopathological consequences of middle cerebral artery occlusion in the rat. J Cereb Blood Flow Metab 12:380-389, 1992
34. Nagasawa H, Kogure K: Correlation between cerebral blood flow and histologic changes in a new rat model of middle cerebral artery occlusion. Stroke 20:1037-1043, 1989
35. Ogita K, Ohkawara A, Suzuki T, et al: Effects of ifenprodil on the N-methyl-D-aspartate receptor ionophore complex in rat brain. Neurochem Int 21:135-147, 1992
36. Poignet H, Nowicki JP, Scatton B: Lack of neuroprotective effect of some a ligands in a model of focal cerebral ishemia in the mouse. Brain Res 596:320-324, 1992
37. 3H] MK-801 binding to the N-methyl-D-aspartate receptor-ion channel complex by L-glutamate, glycine, and polyamines. J Neurochem 51:830-836, 1988
38. Reynolds U, Miller RJ: Ifenprodil is a novel type of N-methyl-D-aspartate receptor antagonist: interaction with polyamines. Mol Pharmacol 36:758-765, 1989
39. 3H]ifenprodil, a novel NMDA antagonist, to a polyamine-sensitive site in the rat cerebral cortex. Eur J Pharmacol 176:249-250, 1990
40. Shalaby IA, Chenard BL, Prochniak MA, et al: Neuroprotective effects of the N-methyl-D-aspartate receptor antagonists ifenprodil and SL-82,0715 on hippocampal cells in culture. J Pharmacol Exp Ther 260:925-932, 1992
41. Siesjö BK: Pathophysiology and treatment of focal cerebral ischemia, Part I. Pathophysiology. J Neurosurg 77:169-184, 1992
42. Sprosen TS, Woodruff GN: Polyamines potentiate NMDA induced whole-cell currents in cultured striatal neurons. Eur J Pharmacol 179:477-478, 1990
43. Tamura Y, Sato Y, Yokota T, et al: Ifenprodil prevents glutamate cytotoxicity via polyamine modulatory sites of N-methyl-D-aspartate receptors in cultured cortical neurons. J Pharmacol Exp Ther 265:1017-1025, 1993
44. Uyama O, Okamura N, Yanase M, et al: Quantitative evaluation of vascular permeability in the gerbil brain after transient ischemia using Evans blue fluorescence. J Cereb Blood Flow Metab 8:282-284, 1988
45. Watkins JC, Olverman HJ: Agonists and antagonists for excitatory amino acid receptors. Trends Neurosci 10:265-272, 1987
46. Williams K, Romano C, Dichter MA, et al: Modulation of the NMDA receptor by polyamines. Life Sci 48:469-498, 1991
47. Yang GY, Betz AL: Reperfusion-induced injury to the blood-brain barrier after middle cerebral artery occlusion in rats. Stroke 25:1658-1665, 1994
48. Young AR, Bouloy M, Boussard JF, et al: Direct vascular effects of agents used in the pharmacotherapy of cerebrovascular disease on isolated cerebral vessels. J Cereb Blood Flow Metab 1:117-128, 1981